Skip to main content
. 2010 Aug 17;2:101–119. doi: 10.2147/DHPS.S6317

Figure 1.

Figure 1

Targets of current biological therapies for RA.

Note: *Developed and assessed in clinical trials, but not yet widely available.

Abbreviations: CTLA 4, cytotoxic T-lymphocyte antigen 4; CD, cluster of differentiation.